Citi cuts iron ore price forecasts

Alexander Bueso Sharecast | 19 Jun, 2017 11:51 | | |

mining truck, commodities, minerals, iron ore

Analysts at Citi lowered their forecasts for the price of iron ore over the next twelve months, telling clients that lower prices were needed in order for the market to re-balance and in anticipation of waning Chinese growth.

Their new forecasts called for an average price of $61 per tonne in 2017 and $50 per tonne between 2018 and 2020.

A near-term trough in prices - with spot prices dropping to the low $40s - was possible over the next six to eight months, they said.

Chinese blast furnace utilisation had already hit a near-term peak while steel scrap was reducing demand.

In parallel, iron ore inventories should peak in the back-half of 2017, they added, falling gradually thereafter without tightening balances.

Current expansion projects by the big miners should also add about 60Mt of supplies in 2017, the broker said.

"The market needs iron ore prices below $45/t to re-balance. Chinese growth momentum should wane, and credit tightness should lead to more de-stocking ahead," Citi said.

To take note of, in a separate note analysts at Citi maintained their 'buy' recommendation on shares of Rio Tinto but lowered their target price to 3,400p.

On a related note, on Friday analysts at Macquarie trimmed their own price projection for spot iron ore in 2017 by 1.6%.

Analysts at the Australian broker forecast spot iron would be at $50 per tonne in the second half of 2017, versus $61 over the second quarter.

While China's slowing property market was now the risk, Macquarie said demand for commodities was not weak, the global recovery had held up well - especially outside China.

"Over the rest of 2017 we continue to avoid those commodities most closely linked to [China's slowing property market], and/or where the supply response to higher prices has been strong, such as coking coal and iron ore. We are more favourable to those whose direction comes from other parts of the world, such as precious metals, or have a compelling supply case, such as zinc and lead."

More news

19 Aug US close: Stocks end lower despite Bannon departure

Wall Street slipped slight lower heading into the weekend as traders tried to figure out the implications of recent events on Capitol Hill and weighed the unexpected departure of White House chief strategist Steven Bannon.

18 Aug Europe close: Stocks edge slightly higher at the end of the session

Stocks pared early losses as traders digested a terrorist attack on Barcelona overnight and monitored the news-flow coming from the White House.

18 Aug Weeky review

The FTSE 100 finished the week almost flat, up 14.02 points or 0.19%, at 7,323.98.

18 Aug London close: Risk aversion grips FTSE, stocks lower on Trump and Barcelona attacks

London's FTSE 100 index fell below a key technical level as Friday's session wore on, with travel stocks leading the retreat after the terror attacks in Barcelona and the large cabal of overseas focused companies hit by the dollar's weakness amid renewed concerns about the US Presidency.

18 Aug BowLeven appoints new director

AIM-listed oil and gas group, BowLeven announced on Friday that Matt McDonald would be appointed to the firm's board as non-executive director with immediate effect.

18 Aug Week ahead: Not everything that happens at Jackson Hole stays there

In the coming week, the spotlight will be on the Federal Reserve bank of Kansas City's Symposium in Jackson Hole, Wyoming.

18 Aug Acacia remains a 'buy' for HSBC but target price slashed

HSBC cut its target price for Acacia Mining by 47% but kept its 'buy' recommendation in place as the months-long spat with the Tanzanian government still hangs over the company.

18 Aug US open: Stocks flat heading into the weekend, political ruckus weighs

Wall Street is essentially flat heading into the weekend after the head of the University of Michigan's consumer confidence survey said recent events in Charlottesville were likely to take their toll on sentiment.

18 Aug FTSE 250 movers: Hikma still looking ill; Kaz Minerals buffs up

Hikma Pharmaceuticals shares continued their downward spiral as HSBC slashed their target price, telling clients its first half numbers contained lower guidance for generics and a tougher outlook for injectables and branded drugs.

18 Aug Calpine agrees to be acquired for $5.6bn in cash

Shares of Calpine Corporation surged after news broke that the American power generation company had agreed to be acquired by a consortium led by Energy Capital Partners.